Decoding Recent FDA and Health Canada Updates: Implications for Pharmaceutical Product Approvals
FDA and Health Canada updates tighten timelines, increase evidence demands, and require eCTD v4.0 submissions. Leverage accelerated pathways (PDUFA, NOC/c) and ICH Q12 for post-approval management.
